Purpose: The absorption, distribution, metabolism, and excretion of the hedgehog pathway inhibitor sonidegib (LDE225) were determined in healthy male subjects. Methods: Six subjects received a single oral dose of 800 mg 14C-sonidegib (74 kBq, 2.0 μCi) under fasting conditions. Blood, plasma, urine, and fecal samples were collected predose, postdose in-house (days 1-22), and during 24-h visits (weekly, days 29-43; biweekly, days 57-99). Radioactivity was determined in all samples using accelerator mass spectrometry (AMS). Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used to determine concentrations of sonidegib and its main circulating metabolite in plasma. Metabolite profiles and structures were determined in pooled plasma,...
Introduction: Positron emission tomography (PET) has enabled us to directly explore the pharmacokine...
Purpose: To explore, in a microdose (phase-0) study, the pharmacokinetics, bioavailability and conce...
The present article summarizes Metabolites in Safety Testing (MIST) studies on a glucokinase activat...
Purpose: This phase I trial was undertaken to determine the maximum tolerated dose (MTD), doselimiti...
Sonidegib (Odomzo®) is an orally available Smoothened inhibitor for the treatment of advanced basal ...
Purpose This study aimed to determine the pharmacokinetics of the p110α-selective inhibitor alpelis...
Hedgehog inhibitors are promising alternative treatments for patients with advanced basal cell carci...
Sonidegib is a selective inhibitor of Smoothened receptor, which is a key regulator of the Hedgehog ...
1. Naldemedine is a peripherally acting μ-opioid receptor antagonist for the treatment of opioid-ind...
Summary: Plitidepsin (Aplidin®) is a marine-derived anticancer compound currently investigated in ph...
<p>1.The absorption, distribution, metabolism and excretion of enasidenib were studied following a s...
PURPOSE: Plitidepsin absorption, distribution, metabolism and excretion characteristics were investi...
The Author(s) 2012. This article is published with open access at Springerlink.com Purpose To invest...
The objectives of this study were to determine the absolute bioavailability of lesinurad and to char...
Introduction: Hedgehog inhibitors are an alternative treatment option for patients with advanced BCC...
Introduction: Positron emission tomography (PET) has enabled us to directly explore the pharmacokine...
Purpose: To explore, in a microdose (phase-0) study, the pharmacokinetics, bioavailability and conce...
The present article summarizes Metabolites in Safety Testing (MIST) studies on a glucokinase activat...
Purpose: This phase I trial was undertaken to determine the maximum tolerated dose (MTD), doselimiti...
Sonidegib (Odomzo®) is an orally available Smoothened inhibitor for the treatment of advanced basal ...
Purpose This study aimed to determine the pharmacokinetics of the p110α-selective inhibitor alpelis...
Hedgehog inhibitors are promising alternative treatments for patients with advanced basal cell carci...
Sonidegib is a selective inhibitor of Smoothened receptor, which is a key regulator of the Hedgehog ...
1. Naldemedine is a peripherally acting μ-opioid receptor antagonist for the treatment of opioid-ind...
Summary: Plitidepsin (Aplidin®) is a marine-derived anticancer compound currently investigated in ph...
<p>1.The absorption, distribution, metabolism and excretion of enasidenib were studied following a s...
PURPOSE: Plitidepsin absorption, distribution, metabolism and excretion characteristics were investi...
The Author(s) 2012. This article is published with open access at Springerlink.com Purpose To invest...
The objectives of this study were to determine the absolute bioavailability of lesinurad and to char...
Introduction: Hedgehog inhibitors are an alternative treatment option for patients with advanced BCC...
Introduction: Positron emission tomography (PET) has enabled us to directly explore the pharmacokine...
Purpose: To explore, in a microdose (phase-0) study, the pharmacokinetics, bioavailability and conce...
The present article summarizes Metabolites in Safety Testing (MIST) studies on a glucokinase activat...